Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Wei Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6244-3187; OpenAlex author ID A5100323732. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers

Papers 12

  1. Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis-Based Pancreatic Ductal Adenocarcinoma Therapy. Co-author DOI 10.1002/adma.202412982↗
  2. Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics. Last author DOI 10.1186/s12876-025-04507-5↗
  3. Recent advances in sonodynamic therapy strategies for pancreatic cancer. Last author DOI 10.1002/wnan.1945↗
  4. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2024.2322173↗
  5. WITHDRAWN: Exogenous HMGB1 promotes pancreatic cancer progression by supporting the crosstalk between tumor and myeloid-derived suppressor cell First author DOI 10.21203/rs.3.rs-3886646/v1↗
  6. Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-023-48852-5↗
  7. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis. Co-author DOI 10.3389/fimmu.2022.1022420↗
  8. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21Waf1 signalling pathway. Co-author DOI 10.1139/bcb-2018-0230↗
  9. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Co-author DOI 10.1002/cbf.3278↗
  10. Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling. Co-author DOI 10.1016/j.yexcr.2016.06.001↗
  11. MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep22793↗
  12. Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression. Co-author DOI 10.1038/ncomms8184↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Cao · 2 shared papers, 2024–2025 · strength 0.51
  2. Ding-Fang Cai · 2 shared papers, 2016–2023 · strength 0.29
  3. Chenye Shi · 2 shared papers, 2016–2023 · strength 0.29
  4. Dansong Wang · 2 shared papers, 2016–2023 · strength 0.29
  5. Faming Wang · 1 shared paper, 2024 · strength 0.28
  6. Liqin Li · 1 shared paper, 2024 · strength 0.28
  7. Ning Wang · 1 shared paper, 2024 · strength 0.28
  8. Dan Shi · 1 shared paper, 2025 · strength 0.27
  9. Xiaohong Shen · 3 shared papers, 2016–2020 · strength 0.26
  10. Peng Cheng · 1 shared paper, 2024 · strength 0.24
  11. Shuai Ming · 1 shared paper, 2024 · strength 0.24
  12. Chaoqiang Qiao · 1 shared paper, 2025 · strength 0.22
  13. Changhong Shi · 1 shared paper, 2025 · strength 0.22
  14. Zhongliang Wang · 1 shared paper, 2025 · strength 0.22
  15. Yue Fan · 1 shared paper, 2023 · strength 0.22
  16. Xiangmin Tong · 1 shared paper, 2024 · strength 0.22
  17. Shibing Wang · 1 shared paper, 2024 · strength 0.22
  18. Shaoxia Du · 2 shared papers, 2017–2020 · strength 0.20
  19. Hui Wang · 2 shared papers, 2017–2020 · strength 0.20
  20. Jun Cai · 2 shared papers, 2017–2020 · strength 0.20
  21. Hongkun Zhou · 1 shared paper, 2022 · strength 0.16
  22. Hongzhu Yu · 1 shared paper, 2022 · strength 0.16
  23. Tao Zhang · 1 shared paper, 2022 · strength 0.16
  24. Liang Chen · 1 shared paper, 2022 · strength 0.16
  25. Beibei Xin · 2 shared papers, 2016–2017 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.